Why We Built Covalenty
Independent pharmacies in Brazil spend hours every week calling distributors just to figure out who has stock and at what price. We started Covalenty to fix that.
Read articleArticles on pharmaceutical procurement, ANVISA compliance, distributor networks, and how to buy smarter in Brazil.
Independent pharmacies in Brazil spend hours every week calling distributors just to figure out who has stock and at what price. We started Covalenty to fix that.
Read articleIn our first cohort of pilot pharmacies across Sao Paulo, participants compared prices across three or more distributors on every order. Here is what they found.
Read articleThe government price caps for regulated medications were updated in early 2026. This is a plain-language summary of what changed and how it affects what you pay distributors.
Read articleThe concern is real: giving a new platform access to your ordering process is a risk. We explain what trust signals matter most to small pharmacy operators.
Read articleCompliance requirements for independent pharmacies in Brazil are detailed. This checklist covers the procurement-related requirements that affect how and where you source medications.
Read articleMatching buyers and sellers in pharmaceutical distribution involves thousands of SKUs, shifting inventory, and price caps. AI-powered search and ranking are beginning to change how that matching works.
Read articleThe pharmaceutical distribution market in Brazil is highly fragmented. Without transparency, small buyers consistently pay more than large chain buyers for identical products.
Read articleMost independent pharmacy owners spend more time on procurement phone calls than they realize. We calculated what that time actually costs and what it buys.
Read articleBrazil has over 120 licensed pharmaceutical distributors. Most independent pharmacies work with three or four at most. We explain why the network is bigger than it looks from a small pharmacy counter.
Read articleThere are tens of thousands of independent pharmacies operating in Brazil outside the major chains. They face structural disadvantages in procurement that this article explores in detail.
Read articleMany small pharmacies still track distributor prices in spreadsheets updated manually. The gap between that and AI-assisted procurement is smaller than most expect.
Read articleCovalenty launched this year with a single goal: give independent pharmacies in Brazil the same pricing information that big chains have had for years.
Read article